Lombard Medical, Inc. (EVARF)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 29, 2025
Lombard Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | 2007 - 2011 |
---|---|---|---|---|---|---|
Period Ending | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | 2007 - 2011 |
Net Income | -31.04 | -37.8 | -34.75 | -19.2 | -13.16 | Upgrade
|
Depreciation & Amortization | 1.3 | 1.43 | 1.17 | 0.55 | 0.31 | Upgrade
|
Other Amortization | 1.04 | 0.48 | - | 0.03 | - | Upgrade
|
Loss (Gain) From Sale of Assets | 0.39 | 0.07 | - | - | - | Upgrade
|
Asset Writedown & Restructuring Costs | 3.36 | - | - | - | - | Upgrade
|
Stock-Based Compensation | 1.11 | 2.78 | 2.54 | 1.18 | -0.41 | Upgrade
|
Other Operating Activities | 1.94 | 0.98 | -0.22 | -0.89 | 1.3 | Upgrade
|
Change in Accounts Receivable | 0 | -0.19 | -0.48 | -1.92 | 0.52 | Upgrade
|
Change in Inventory | -1.48 | -1.78 | -1.84 | -0.12 | 0.56 | Upgrade
|
Change in Accounts Payable | -1.82 | 0.23 | -0.79 | 2.6 | -1.03 | Upgrade
|
Operating Cash Flow | -25.2 | -33.8 | -34.37 | -17.79 | -11.91 | Upgrade
|
Capital Expenditures | -0.27 | -1.24 | -1.48 | -1.81 | -0.22 | Upgrade
|
Sale of Property, Plant & Equipment | 0.12 | - | - | - | - | Upgrade
|
Cash Acquisitions | - | -0.2 | - | - | - | Upgrade
|
Sale (Purchase) of Intangibles | - | -0.02 | -0.27 | -2.07 | - | Upgrade
|
Other Investing Activities | 0.05 | 0.09 | 0.17 | - | - | Upgrade
|
Investing Cash Flow | -0.09 | -1.37 | -1.58 | -3.88 | -0.22 | Upgrade
|
Long-Term Debt Issued | 12.41 | 21 | - | 2.5 | 4.78 | Upgrade
|
Total Debt Issued | 12.41 | 21 | - | 2.5 | 4.78 | Upgrade
|
Long-Term Debt Repaid | - | -5.33 | - | - | - | Upgrade
|
Total Debt Repaid | - | -5.33 | - | - | - | Upgrade
|
Net Debt Issued (Repaid) | 12.41 | 15.67 | - | 2.5 | 4.78 | Upgrade
|
Issuance of Common Stock | 5 | - | 55 | 55.34 | - | Upgrade
|
Other Financing Activities | -1.6 | -1.13 | -5.34 | -2.18 | -0.25 | Upgrade
|
Financing Cash Flow | 15.81 | 14.54 | 49.66 | 55.66 | 4.53 | Upgrade
|
Foreign Exchange Rate Adjustments | -2.05 | -0.38 | -1.24 | 2.42 | 0.43 | Upgrade
|
Net Cash Flow | -11.54 | -21 | 12.47 | 36.42 | -7.17 | Upgrade
|
Free Cash Flow | -25.46 | -35.04 | -35.85 | -19.6 | -12.13 | Upgrade
|
Free Cash Flow Margin | -209.22% | -231.81% | -270.05% | -281.59% | -196.42% | Upgrade
|
Free Cash Flow Per Share | -1.26 | -1.97 | -2.46 | -2.18 | -2.41 | Upgrade
|
Cash Interest Paid | 1.45 | 0.69 | - | 0.16 | 0.29 | Upgrade
|
Cash Income Tax Paid | 0.01 | -2.58 | -1.17 | 0.03 | -1.48 | Upgrade
|
Levered Free Cash Flow | -17.21 | -20.31 | -22.8 | -15.12 | -8.05 | Upgrade
|
Unlevered Free Cash Flow | -15.94 | -19.69 | -22.75 | -14.84 | -7.63 | Upgrade
|
Change in Net Working Capital | 2.97 | -1.43 | 3.07 | 0.19 | -0.87 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.